Interestingly, decitabine was able to suppress Eμ-driven translocated MYC through upregulation of NF-ĸB and ID2 and thereby inhibit cell proliferation in Burkitt’s lymphoma [152]. Here, MYC is linked to Burkitt lymphoma.